These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11288327)
1. Nutritional and medical therapy for dyslipidemia in patients with cardiovascular disease. Logan P; Clarke S AACN Clin Issues; 2001 Feb; 12(1):40-52. PubMed ID: 11288327 [TBL] [Abstract][Full Text] [Related]
2. Management of dyslipidaemia. Thompson GR Heart; 2004 Aug; 90(8):949-55. PubMed ID: 15253984 [No Abstract] [Full Text] [Related]
4. Medical management of hyperlipidemia/dyslipidemia. Kreisberg RA; Oberman A J Clin Endocrinol Metab; 2003 Jun; 88(6):2445-61. PubMed ID: 12788840 [No Abstract] [Full Text] [Related]
5. The treatment of hypertension and dyslipidemia in diabetes mellitus. Fineberg SE Prim Care; 1999 Dec; 26(4):951-64. PubMed ID: 10523469 [TBL] [Abstract][Full Text] [Related]
10. Severely frail elderly patients do not need lipid-lowering drugs. Mallery LH; Moorhouse P; McLean Veysey P; Allen M; Fleming I Cleve Clin J Med; 2017 Feb; 84(2):131-142. PubMed ID: 28198686 [TBL] [Abstract][Full Text] [Related]
11. Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal disease. Trovati M; Cavalot F J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S12-20. PubMed ID: 14684665 [TBL] [Abstract][Full Text] [Related]
12. Hyperlipidemia and its management in renal disease. Massy ZA; Kasiske BL Curr Opin Nephrol Hypertens; 1996 Mar; 5(2):141-6. PubMed ID: 8744535 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological management of dyslipidemia in high and very high cardiovascular risk patients. Pascual Fuster V Rev Esp Sanid Penit; 2016 Dec; 18(3):95-108. PubMed ID: 27831597 [TBL] [Abstract][Full Text] [Related]
14. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia. Baron M Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907 [No Abstract] [Full Text] [Related]
16. How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease? A response to Grover et al. Egede LE Diabetes Care; 2001 Jul; 24(7):1306-7. PubMed ID: 11423528 [No Abstract] [Full Text] [Related]
17. Currently available lipid-lowering agents. Levy RI Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381 [No Abstract] [Full Text] [Related]
18. Current topics on hypolipidaemic therapy and cardiovascular risk assessment. Rizos EC; Elisaf MS Curr Vasc Pharmacol; 2010 Sep; 8(5):587-8. PubMed ID: 20572807 [No Abstract] [Full Text] [Related]
19. Cardiovascular disease and dyslipidemia in women. Welty FK Arch Intern Med; 2001 Feb; 161(4):514-22. PubMed ID: 11252110 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor? Rabelink TJ Nephrol Dial Transplant; 2004 Jan; 19(1):23-6. PubMed ID: 14671033 [No Abstract] [Full Text] [Related] [Next] [New Search]